We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Safety of PSMA-targeted molecular radioligand therapy with <sup>177</sup>Lu-PSMA-617: results from the prospective multicenter phase 2 trial RESIST-PC NCT03042312.
- Authors
Calais, Jeremie; Czernin, Johannes; Thin, Pan; Gartmann, Jeannine; Nguyen, Kathleen; Armstrong, Wesley R; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan 5; Gardner, Linda; Dahlbom, Magnus; He, Beilei; Esfandiari, Rouzbeh; Ranganathan, David; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang P.; Delpassand, Ebrahim
- Publication
Journal of Nuclear Medicine, 2021, Vol 62, Issue 12, p1
- ISSN
0161-5505
- Publication type
Article
- DOI
10.2967/jnumed.121.262543